Animal models of pain: diversity and benefits

C Abboud, A Duveau, R Bouali-Benazzouz… - Journal of neuroscience …, 2021 - Elsevier
Chronic pain is a maladaptive neurological disease that remains a major health problem. A
deepening of our knowledge on mechanisms that cause pain is a prerequisite to developing …

Anti‐nerve growth factor monoclonal antibodies for the control of pain in dogs and cats

M Enomoto, PW Mantyh, J Murrell, JF Innes… - Veterinary …, 2019 - Wiley Online Library
Nerve growth factor (NGF) is essential for the survival of sensory and sympathetic neurons
during development. However, in the adult, NGF and its interaction with tropomyosin …

2022 AAHA pain management guidelines for dogs and cats

ME Gruen, BDX Lascelles… - Journal of the …, 2022 - meridian.allenpress.com
These updated guidelines present a practical and logical approach to the assessment and
management of acute and chronic pain in canine and feline patients. Recognizing pain is …

2022 WSAVA guidelines for the recognition, assessment and treatment of pain

BP Monteiro, BDX Lascelles, J Murrell… - Journal of Small …, 2023 - Wiley Online Library
Animal sentience refers to the capacity of animals to feel both positive and negative
emotions including that of pain. As veterinary health professionals, we have a medical and …

2021 AAFP feline senior care guidelines

M Ray, HC Carney, B Boynton… - Journal of Feline …, 2021 - journals.sagepub.com
The '2021 AAFP Feline Senior Care Guidelines' are authored by a Task Force of experts in
feline clinical medicine and serve as an update and extension of those published in 2009 …

Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

ME Gruen, JAE Myers, JKS Tena… - Journal of Veterinary …, 2021 - Wiley Online Library
Background Frunevetmab, a felinized antinerve growth factor monoclonal antibody,
effectively decreases osteoarthritis (OA) pain in cats. Objective To evaluate the efficacy of …

Translational pain assessment: could natural animal models be the missing link?

MP Klinck, JS Mogil, M Moreau, BDX Lascelles… - Pain, 2017 - journals.lww.com
Failure of analgesic drugs in clinical development is common. Along with the current
“reproducibility crisis” in pain research, this has led some to question the use of animal …

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models

D Britti, R Crupi, D Impellizzeri, E Gugliandolo… - BMC veterinary …, 2017 - Springer
Background Osteoarthritis (OA) is a common progressive joint disease in dogs and cats. The
goal of OA treatment is to reduce inflammation, minimize pain, and maintain joint function …

Caregiver placebo effect in analgesic clinical trials for cats with naturally occurring degenerative joint disease‐associated pain

ME Gruen, DC Dorman, BDX Lascelles - Veterinary Record, 2017 - Wiley Online Library
A literature review identified six placebo‐controlled studies of analgesics in client‐owned
cats with degenerative joint disease‐associated pain. Five studies with 96 cats had …

The pharmacokinetics of gabapentin in cats

D Adrian, MG Papich, R Baynes… - Journal of veterinary …, 2018 - Wiley Online Library
Background Gabapentin is the most commonly prescribed medication for the treatment of
chronic musculoskeletal pain in cats. Despite this common and chronic usage, clinically …